Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 145

Results For "Group"

1695 News Found

Al-Futtaim partners with TytoCare to expand digital health services
Digitisation | January 24, 2022

Al-Futtaim partners with TytoCare to expand digital health services

Al-Futtaim will utilize TytoCare's TytoPro system in outpatient clinics around Dubai, providing patients with enhanced care and better access to specialists


USFDA expands use of Remdesivir  for Covid-19
News | January 22, 2022

USFDA expands use of Remdesivir for Covid-19

Previously, the use of the drug was limited to patients requiring hospitalization


Lannett receives USFDA safety review for biosimilar insulin glargine
Biotech | January 22, 2022

Lannett receives USFDA safety review for biosimilar insulin glargine

Go-ahead for pivotal clinical trial which is expected to commence by March


Molnupiravir reduces risk of hospitalisation by 30% : Dr Shashank Joshi
News | January 22, 2022

Molnupiravir reduces risk of hospitalisation by 30% : Dr Shashank Joshi

Omicron patients below 60 with no comorbidities can start treatment with paracetamol


Sputnik V demonstrates better protection compared to Pfizer against Omicron: Study
News | January 21, 2022

Sputnik V demonstrates better protection compared to Pfizer against Omicron: Study

An article by a team of 12 Italian and 9 Russian scientists led by Francesco Vaia, Director of the Spallanzani Institute and Alexander Gintsburg, Director of the Gamaleya Center, has been published in medRxiv


Zydus receives final approval from USFDA for Vigabatrin tablets
Drug Approval | January 20, 2022

Zydus receives final approval from USFDA for Vigabatrin tablets

Vigabatrin is an anticonvulsant. It is known to work by stopping the breakdown of a natural calming substance (GABA) in the brain


Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool
News | January 20, 2022

Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool

They will commercialize molnupiravir in the international markets


Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer
Biotech | January 19, 2022

Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer

These results will be presented on 21 January at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium


Healthcare for seniors an opportunity for service providers
Public Health | January 19, 2022

Healthcare for seniors an opportunity for service providers

Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas


Menarini Diagnositcs PCR kit identifies Omicron variant
Medical Device | January 18, 2022

Menarini Diagnositcs PCR kit identifies Omicron variant

It provides Covid-19 detection and Omicron surveillance in less than two hours